Dr Jan van de Loosdrecht
Dr Jan van Loosdrecht joined the CSIR in October 2019 as the Executive Manager for the Future Production: Chemicals cluster. In this role, he is responsible for providing strategic direction, financial sustainability, capability development, performance, operations and governance within the cluster, in line with the trends, opportunities and needs of the chemicals, pharmaceuticals and related industries, and in line with the CSIR Strategy, vision and mission.
CSIR researchers are exploring the synthesis, modification and composting of porous carbonaceous materials for hydrogen storage applications.
The CSIR coastal flood risk viewer is an interactive web-based tool to visualise the extent of coastal flooding in specific areas.
The CSIR has developed a technology to provide long-range, broadband access to underserved and hard-to-reach communities and facilities.
Adv Esmé Kennedy
Adv. Esmé Kennedy is the CSIR Group Executive: Legal, Compliance and Business Enablement. She joined the CSIR in August 2018 from Yokogawa South Africa (Pty) Ltd, where she was Executive Manager: Business Support Services. She has a wealth of experience, which spans over 15 years, eight of which were at senior management level.
Dr Rachel Chikwamba
Dr Rachel Chikwamba is the CSIR Group Executive: Advanced Chemistry and Life Sciences division. In this role, she leads the implementation of the CSIR Strategy in the respective sectors, working closely with academia, and the public and private sector partners locally and internationally to contribute to improved sectoral competitiveness and economic performance through innovation.
The CSIR is developing adaptation guidelines for various types of human settlements in South Africa that are at risk because of climate change.
The CSIR, in collaboration with Cape Aerospace Technologies and Stellenbosch University, is working on a 200 N (Newton) micro gas turbine engine for the hobby market, unmanned aerial vehicles (UAVs
The CSIR, in collaboration with the University of Pretoria, is working on developing a feasible prototype diagnostic devices to supplement existing technologies for tuberculosis (TB) diagnosis wher
The CSIR has developed technology to provide small, medium, and large enterprises with software that detects network invasion at an early stage, to avoid disclosure of sensitive information and eve